Serena Luchenski1,2, Lianping Ti2, Kanna Hayashi2,3, Huiru Dong2, Evan Wood2, Thomas Kerr4. 1. The Farr Institute of Health Informatics Research, University College London, London, UK. 2. Urban Health Research Initiative, British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, Canada. 3. Division of AIDS, Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada. 4. Urban Health Research Initiative, British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, Canada. uhri-tk@cfenet.ubc.ca.
Abstract
INTRODUCTION AND AIMS: Strategies are needed to transition persons who inject drugs out of injecting. We undertook this study to identify protective factors associated with cessation of injection drug use. DESIGN AND METHODS: Data were derived from three prospective cohorts of people who use illicit drugs in Vancouver, Canada, between September 2005 and November 2011. Generalised estimating equations were used to examine protective factors and 6-month cessation of injection drug use. RESULTS: Our sample of 1663 people who inject drugs included 563 (33.9%) women, and median age was 40 years. Overall, 904 (54.4%) individuals had at least one 6-month injection cessation event. In multivariable analysis, protective factors associated with cessation of injection drug use included the following: having a regular place to stay [adjusted odds ratio (AOR) = 1.30; 95% confidence interval (CI) 1.13-1.48]; formal employment (AOR = 1.12; 95% CI 1.01-1.23); social support from personal contacts (AOR = 1.22; 95% CI 1.10-1.35); social support from professionals (AOR = 1.26; 95% CI 1.14-1.39); ability to access health and social services (AOR = 1.21; 95% CI 1.09-1.34); and positive self-rated health (AOR = 1.21, 95% CI 1.11-1.32). DISCUSSION AND CONCLUSIONS: Over half of people who inject drugs in this study reported achieving 6-month cessation of injection drug use, with cessation being associated with a range of modifiable protective factors. Policy makers and practitioners should promote increased access to stable housing, employment, social support and other services to promote cessation of injection drug use. [Luchenski S, Ti L, Hayashi K, Dong H, Wood E, Kerr T. Protective factors associated with short-term cessation of injection drug use among a Canadian cohort of people who inject drugs Drug Alcohol Rev 2016;35:620-627].
INTRODUCTION AND AIMS: Strategies are needed to transition persons who inject drugs out of injecting. We undertook this study to identify protective factors associated with cessation of injection drug use. DESIGN AND METHODS: Data were derived from three prospective cohorts of people who use illicit drugs in Vancouver, Canada, between September 2005 and November 2011. Generalised estimating equations were used to examine protective factors and 6-month cessation of injection drug use. RESULTS: Our sample of 1663 people who inject drugs included 563 (33.9%) women, and median age was 40 years. Overall, 904 (54.4%) individuals had at least one 6-month injection cessation event. In multivariable analysis, protective factors associated with cessation of injection drug use included the following: having a regular place to stay [adjusted odds ratio (AOR) = 1.30; 95% confidence interval (CI) 1.13-1.48]; formal employment (AOR = 1.12; 95% CI 1.01-1.23); social support from personal contacts (AOR = 1.22; 95% CI 1.10-1.35); social support from professionals (AOR = 1.26; 95% CI 1.14-1.39); ability to access health and social services (AOR = 1.21; 95% CI 1.09-1.34); and positive self-rated health (AOR = 1.21, 95% CI 1.11-1.32). DISCUSSION AND CONCLUSIONS: Over half of people who inject drugs in this study reported achieving 6-month cessation of injection drug use, with cessation being associated with a range of modifiable protective factors. Policy makers and practitioners should promote increased access to stable housing, employment, social support and other services to promote cessation of injection drug use. [Luchenski S, Ti L, Hayashi K, Dong H, Wood E, Kerr T. Protective factors associated with short-term cessation of injection drug use among a Canadian cohort of people who inject drugs Drug Alcohol Rev 2016;35:620-627].
Authors: Arijit Nandi; Thomas A Glass; Stephen R Cole; Haitao Chu; Sandro Galea; David D Celentano; Gregory D Kirk; David Vlahov; William W Latimer; Shruti H Mehta Journal: Am J Epidemiol Date: 2010-01-21 Impact factor: 4.897
Authors: Steffanie A Strathdee; Timothy B Hallett; Natalia Bobrova; Tim Rhodes; Robert Booth; Reychad Abdool; Catherine A Hankins Journal: Lancet Date: 2010-07-24 Impact factor: 79.321
Authors: Michael-John S Milloy; Brandon D L Marshall; Thomas Kerr; Jane Buxton; Tim Rhodes; Julio Montaner; Evan Wood Journal: AIDS Date: 2012-06-01 Impact factor: 4.177
Authors: Becky L Genberg; Stephen J Gange; Vivian F Go; David D Celentano; Gregory D Kirk; Shruti H Mehta Journal: Am J Epidemiol Date: 2011-02-13 Impact factor: 4.897
Authors: Joseph Cox; Emilie Maurais; Lina Hu; Erica E M Moodie; Stephanie Law; Nikki Bozinoff; Martin Potter; Kathleen Rollet; Mark Hull; Mark Tyndall; Curtis Cooper; John Gill; Sahar Saeed; Marina B Klein Journal: Drug Alcohol Depend Date: 2014-01-30 Impact factor: 4.492
Authors: Danielle Horyniak; Steffanie A Strathdee; Brooke S West; Meredith Meacham; Gudelia Rangel; Tommi L Gaines Journal: Drug Alcohol Depend Date: 2018-02-21 Impact factor: 4.492